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Complex molecular interactions dictate the develop-
mental steps that lead to a mature and functional
cornea and lens. Peters anomaly is one subtype of
anterior segment dysgenesis especially due to abnor-
mal development of the cornea and lens. MSX2 was
recently implicated as a potential gene that is critical
for anterior segment development. However, the role
of MSX2 within the complex mechanisms of eye de-
velopment remains elusive. Our present study ob-
served the morphologic changes in conventional
Msx2 knockout (KO) mice and found phenotypes
consistent with Peters anomaly and microphthalmia
seen in humans. The role of Msx2 in cornea and lens
development was further investigated using IHC, in
situ hybridization, and quantification of proliferative
and apoptotic lens cells. Loss of Msx2 down-regulated
FoxE3 expression and up-regulated Prox1 and crystal-
lin expression in the lens. The FoxE3 and Prox1 mal-
function and precocious Prox1 and crystallin expres-
sion contribute to a disturbed lens cell cycle in lens
vesicles and eventually to cornea-lentoid adhesions and
microphthalmia in Msx2 KO mice. The observed
changes in the expression of FoxE3 suggest thatMsx2 is
an important contributor in controlling transcription of
target genes critical for early eye development. These
results provide the first direct genetic evidence of the
2230involvement ofMSX2 in Peters anomaly and the distinct
function ofMSX2 in regulating the growth and develop-
ment of lens vesicles. (Am J Pathol 2012, 180:2230–2239;
http://dx.doi.org/10.1016/j.ajpath.2012.02.017)
Anterior segment dysgenesis (ASD) is a developmental
failure of the anterior segment tissues of the eye and an
important cause of severe visual impairment in infants
and young children. ASD has been classified into differ-
ent subtypes based on its specific clinical phenotypes,
including Peters anomaly, aniridia, and Axenfeld-Rieger
syndrome or malformation.1,2 Peters anomaly is due to
the incomplete and delayed detachment of the lens ves-
icle from the surface ectoderm and the persistence of the
lens stalk. The lens adheres to the posterior cornea, lead-
ing to central corneal opacities in deep stromal layers
and local absence of corneal endothelium. In addition,
Peters anomaly is associated with iridiocorneal adhe-
sions, iris hyperplasia, and other developmental eye dis-
orders, such as microphthalmia.3–5
Lens development is a complicated process because
the formation of lens placode derives from the surface ec-
toderm. It has been proposed that abnormalities seen in
Peters anomaly may also result from primary defects in the
lens.6 In human embryos, formation of lens placode takes
place on approximately day 33 of gestation and in mice on
day 9.5 of embryonic development (E9.5).7,8 Coordinated
invagination of the lens ectoderm and the optic vesicle
gives rise to the lens pit and the optic cup and subsequently
a spherical lens vesicle that remains attached to the surface
ectoderm via a transient lens stalk. Detachment of the lens
vesicle from the overlying surface ectoderm and disappear-
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growth and differentiation of the lens vesicle and the forma-
tion of the cornea. At the anterior pole of the lens vesicle,
proliferating lens epithelial cells continue to divide to pro-
duce progenitor cells that migrate to the equatorial region of
the lens, where they exit cell cycle, differentiate into sec-
ondary fiber cells, and elongate to fill the cavity of the ves-
icle. The secondary fibers engulf the primary fiber cells,
which now become denucleated to form the lens nucleus.
Proliferation, migration, and differentiation of the anterior
lens epithelial cells continue throughout the lifespan.9,10
Several genes that are involved in the morphogenetic
processes of anterior eye development have been found to
be associated with ASD, including PAX6, PITX2, PITX3,
FOXC1, FOXE3, SIX3, SOX11, SOX2, and MAF.5,11–17 Stud-
ies have shown that complex molecular interactions dictate
steps of development responsible for mature and functional
cornea and lens.18–20 Among these molecular complexes
aremembers of theBmpsignalingpathway21–24 and its down-
stream nuclear effectors, the MSH homobox genes.25–27
They encode a group of highly conserved homeodomain
proteins that mainly function as transcriptional repres-
sors.28–33 Developmental anomalies as a result of muta-
tions in MSX1 and MSX2 have clearly demonstrated the
importance of these homeodomain transcriptional factors in
controlling the development of the skull, hair follicles, teeth,
heart, and brain.34–40 Consistent with its role in controlling
eye development is our previous finding that overexpres-
sion of the Msx2 gene in transgenic animals resulted in
microphthalmia.41 In the present study, we provide evi-
dence that the Msx2 gene is critically involved in anterior
segment development of the eye. Deletion of Msx2 in mice
can lead to persistent lens stalk with lens and cornea de-
formities that resemble Peters anomaly.
Materials and Methods
Experimental Mouse Breeding and Genotyping
All animal experiments followed the guidelines of the Asso-
ciation for Research in Vision and Ophthalmology State-
ment for the Use of Animals in Ophthalmic and Vision Re-
search. Experimental mice used in this study are
homozygous Msx2-deficient mice (Msx2/)36 and trans-
genic mouse strains R26R,42 Wnt1-Cre,43 and Le-Cre.44
Le-Cre transgenic mice were obtained from David Beebe
(Washington University, St Louis, MO) with permission from
Peter Gruss (Max-Planck Institute for Biophysical Chemis-
try, Gottingen, Germany) and Ruth Ashery-Padan (Tel Aviv
University, Ramat Aviv, Israel). The R26R transgenic strain
was purchased from the Jackson Laboratory (Bar Harbor,
ME). The Wnt1-Cre transgenic strain was obtained from
AndrewMcMahon (Harvard University, Boston, MA). Mouse
genomic DNA was extracted from the embryonic tail tissue
using thehot sodiumhydroxideandTris (HotSHOT)method.45
BrdU Labeling, Isolation, and Preparation of
Mouse Embryos
Timed matings were performed between Msx2 heterozy-
gous (Msx2/) male and female mice to generate ho-mozygous Msx2-deficient (Msx2/) and wild-type (WT)
mouse embryos. The pregnant females were sacrificed at
various time points after conception. One hour before
sacrificing, females were injected intraperitoneally with
100 g of BrdU per gram of body weight. Animals were
sacrificed and embryos were dissected and isolated in
ice-cold PBS. A piece of tail tissue was taken from each
embryo for DNA extraction and identification of the ge-
notype. Then the embryos were fixed in 4% paraformal-
dehyde (PFA) in PBS or in Methyl-Carnoy fixative (60%
methanol, 30% chloroform, and 10% glacial acid) over-
night at 4°C. For histologic analysis, embryos were further
dehydrated through graded alcohols, cleared in xylene,
and embedded in paraffin. Then 5-m sections were cut
for immunohistochemistry (IHC) and H&E staining. For in
situ hybridization analysis, the fixed embryos were rinsed in
PBS for 10 minutes then cryoprotected in 30% sucrose
overnight. Embryos were then oriented in OCT compound
(Sakura Finetek, Torrance, CA) and rapidly frozen. Then
12-m sections were cut and mounted on Superfrost Plus
glass slides (VWR, Brisbane, CA) for future experiments.
Immunohistochemistry
Fixed sections were rehydrated. Endogenous peroxi-
dases were blocked with 3% H2O2. Epitope retrieval was
performed in 0.1M sodium citrate buffer (pH 6.8) at 100°C
for 10 minutes before adding blocking reagents. After the
addition of primary antibodies, sections were incubated
in a humidified chamber at 4°C overnight. The following
primary antibodies were used: mouse monoclonal anti-
Ap2 (Santa Cruz Biotechnology, Santa Cruz, CA),
mouse monoclonal anti-Pax6 (Developmental Studies
Hybridoma Bank, Iowa City, IA), mouse anti-BrdU
(Sigma, St Louis, MO), and rabbit polyclonal anti–-crys-
tallin and anti–-crystallin antibodies (generously pro-
vided by Dr. Samuel Zigler, John Hopkins University,
Baltimore, MD). Fluorophore-labeled anti-mouse IgG an-
tibody (Invitrogen, Carlsbad, CA) was used for signal
acquisition or diaminobenzidine (Zymed, San Francisco,
CA) compound for signal amplification.
TUNEL Assay
Apoptotic cells were detected by using the fluorescein In
situ Cell Death Detection Kit (Roche Applied Science,
Indianapolis, IN). Briefly, 4% PFA-fixed tissue sections
were boiled for 10 minutes. Fragmented DNA was la-
beled with fluorescein-dUTP using terminal transferase.
Fluorescence and bright-field image of sections were
taken using an Olympus microscope (BX51, Olympus,
Center Valley, PA) with a SPOT camera.
-Galactosidase Staining
The Wnt1-Cre mouse line has a -galactosidase reporter
gene in the Rosa26 knock-in allele mediated by the Cre
recombinase, the expression of which is controlled by the
Wnt-1 promoter.43 R26R;Wnt1-Cre mice were crossed
with Msx2/ homozygous mice to generate Msx2/;
R26R;Wnt1-Cre andMsx2/;R26R;Wnt1-Cre genotypes to
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E15.5, embryos were collected and fixed for 30 minutes in
4% PFA, then snap-frozen in OCT freezing media, sec-
tioned, and stained as previously described.35
GFP Fluorescence
The Le-Cre mouse line has a 6.5-kb SacII/XmnI genomic
region, including the upstream regulatory sequences and
the first Pax6 promoter (P0) upstream of sequences en-
coding the nls-Cre, followed by internal ribosome binding
sites and green fluorescent protein (GFP).44 Le-Cre mice
were crossed with Msx2/ homozygous mice to gener-
ate LeCre;Msx2/ and LeCre;Msx2/ genotypes so
that observation of the lens development would be facil-
itated by GFP fluorescence. The pregnant females were
sacrificed at E9.5 to E12.5 after conception. Embryos
were fixed overnight in 4% PFA, embedded in OCT com-
pound, and rapidly frozen in liquid nitrogen. Sections (10
m) were cut for viewing. Fluorescent images were cap-
tured using a fluorescence microscope with a SPOT
camera.
In Situ Hybridization
In situ hybridization was performed as previously de-
Figure 1. Homozygous Msx2-deficient mice (Msx2/) show Peters anom-
aly with microphthalmia compared with WT littermates. Enucleated eyes of
Msx2-deficient mice (arrowhead) at 3 months old were consistently mi-
crophthalmic and 50% smaller in size than eyes of WT littermates (arrow)
(A and B). Smaller palpebral fissure, smaller eyeball, and cornea with cornea
edema were detected in the Msx2-deficient mice (arrow; D) compared with
the WT mice (C). Histologic analysis of the eyes of WT (E) and Msx2-
deficient littermates (F). Thickened cornea, iridiocorneal adhesion, iris hy-
perplasia, and smaller lens were observed in the anterior segment of Msx2-
deficient mice compared with WT mice. The cornea thickness was increased
mainly in stromal layers. The lens was small and pushed toward the cornea
by overproliferated retina and mesenchyme tissues. All of the phenotypes are
consistent with Peters anomaly in the human. Co, cornea; Le, lens; Ret, retnia.scribed.46 The Msx2, Sox2, Mip, Prox1, and Pax6 cDNAplasmids were part of the Mammalian Gene Collection
clones purchased from ATCC (Manassas, VA) or Open
Biosystems (Huntsville, AL). The FoxE3 cDNA plasmid
was kindly provided by Peter Carlsson (University of
Gothenburg, Gothenburg, Sweden). All RNA probes
were labeled with digoxigenin-UTP according to the man-
ufacturer’s recommendations (Roche Applied Science).
The reaction was revealed by immunocytochemistry us-
ing an antidigoxigenin alkaline phosphatase, Fab frag-
ment antibody (Roche Applied Science). The sections
were photographed using Olympus microscope (BX51,
Olympus) with a SPOT camera. When applicable, the
unpaired t-test was used for quantitative analysis using
SPSS software version 13.0 (SPSS Inc, Chicago, IL).
Results
Eyes of Msx2-Deficient Mice Develop Peters
Anomaly with Microphthalmia
Homozygous Msx2-deficient mice showed cornea opac-
ity and edema with microphthalmia compared with that of
the wild-type littermates. Enucleated eyes of Msx2-defi-
cient mice at 3 postnatal months were consistently mi-
crophthalmic and 50% smaller in size than eyes of WT
littermates (Figure 1, A and B). Overall, smaller palpebral
fissure, smaller eyeball, and cornea with cornea edema
were detected in the Msx2-deficient mice. Such pheno-
types became more apparent after the eyelids opened
(Figure 1, C and D). Histologic analysis of the eyes at 3
postnatal weeks disclosed thickened cornea, iridiocor-
neal adhesion, iris hyperplasia, and smaller lens in the
anterior segment compared with that of the WT litter-
mates (Figure 1, E and F). The corneal thickness was
Figure 2. Expression profile of Msx2 during eye development. A: At E9.5,
Msx2 transcripts are present in the optic vesicle (OV) and adjacent ectoderm.
B: At E10.5, a weak hybridization signal forMsx2 emerges in the invaginating
lens placode (Lp), and the signal in the retina (Re) was very weak. C: At
E11.5, a low level expression of Msx2 remained in the lens epithelial (Le)
cells and a moderate signal was found in posterior portion of lens vesicle. D:
At E12.5, an intense Msx2 hybridization signal is localized to the transition
zone and a moderateMsx2 expression is found throughout primary lens fiber
cells but absent from the lens epithelium.
from WT
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pushed toward the cornea by overproliferated retina and
mesenchyme tissues. Ciliary body and iris could not be
distinguished clearly because of overproliferated pig-
ment tissue (Figure 1F). The phenotypes observed are
consistent with Peters anomaly in human.
Examination of eye specimens of the Msx2-deficient
mice from E14 to 3 weeks (n 24) revealed that, besides
abnormalities consistent with Peters anomaly with mi-
crophthalmia, folding of the retina and presence of ecto-
pic pigmented tissue in the vitreous were found in all
eyes. The severity of lens and cornea defects in the eyes
of Msx2-deficient mice varied among animals and even
between eyes of the same animal (data not shown).
Normal Dynamic Expression of Msx2 during
Early-Stage Development of the Eye
Msx2 transcripts were detected in the optic vesicle (Figure
2A) as early as the lens placode stage (E9.5). At E10.5, a
hybridization signal for Msx2 can be found in the invag-
Figure 3. Msx2 inactivation resulted in defective optic vesicle developmen
vesicles from Msx2-deficient mice at E10.5 to E14.5 (A, E, I, and M, respect
detected as early as E10.5 in the optic vesicle compared with that of the litterm
expansion of the RPE as early as E11.5. The anterior movement of the RP
Msx2-deficient mice’s optic vesicles from E10.5 to E14.5 (B, F, J, and N, respe
vesicle smaller and incompletely developed. The lens vesicle in the Msx2-d
mesenchyme. The persistent lens stalk can be seen during lens developmen
to E14.5 (C, G, K, and O, respectively). Histologic sections of optic vesicles
retina; Le, lens.inating lens placode and a weak signal in the retina
(Figure 2B). In the lens vesicle stage (E11.5), Msx2 tran-
scripts were present in low level in the epithelial cells and
moderate level in the posterior portion of the optic vesicle
(Figure 2C). When primary lens fiber cells began to dif-
ferentiate and elongate (E12.5), a moderate Msx2 ex-
pression was found throughout primary lens fiber cells.
Such expression was intense in the transition zone but
absent in the proliferating lens epithelium (Figure 2D).
This early-stage dynamic expression pattern suggests
that Msx2 expression is strictly regulated during eye de-
velopment, especially in induction, invagination, and dif-
ferentiation of the lens vesicle.
Cornea and Lens Development Are Severely
Affected as a Consequence of Targeted
Deletion of Msx2
On gross examination, subtle changes in the eyes of the
Msx2-deficient mice were first detected as early as E10.5
in the optic vesicle, compared with that of the littermate
5 (A–D), E11.5 (E–H), E12.5 (I–L), and E14.5 (M–P). Whole mount of optic
ow subtle changes in the Msx2-deficient eyes. A: These changes were first
trols (arrows). E: The mutant eyes could be easily recognized by the anterior
uced an iris that took on a bowtie-like appearance. Histologic sections of
. Optic vesicle of the Msx2-deficient mice appeared to be larger and the lens
mice appears anamorphic and was compressed by the invading periocular
heads). Whole mount of WT mice’s optic vesicles from WT mice at E10.5
mice at E10.5 to E14.5 (D, H, L, and P, respectively). Lp, lens placode; Re,t at E10.
ively) sh
ate con
E prod
ctively)
eficient
t (arrow
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sections revealed that the optic vesicle of the Msx2-defi-
cient mice appeared to be larger and the lens vesicle
smaller and incompletely developed (Figure 3, B and D).
By E11.5, abnormal development of the mutant eyes
could be easily recognized by the anterior expansion of
the retinal pigmented epithelium (RPE) (Figure 3E). Such
anterior movement of the RPE produced an iris that took
on a bowtie-like appearance. Lens vesicle was com-
pressed by the invading periocular mesenchyme (Figure
3F). Introduction of GFP under the control of Pax6 pro-
moter aided early-stage visualization of lens and lens
stalk (Figure 4, A–D). At E12.5 days, in eyes of the Msx2-
deficient mice, cornea and lens were not separated, the
neural crest cells migrated into the vitreous cavity and
pushed the lens toward the cornea (Figure 3, I and J)
whereas in WT littermates, the lens vesicle and the sur-
face ectoderm were already completely separated and
the space between was filled with invading cells from the
periocular mesenchyme (Figure 3, K and L). Apparently,
this migratory blockade impeded the development of the
cornea in the mutant animals. Eyes of the Msx2-deficient
mice had only a single layer of cornea epithelium cell.
The persistent adherence of the lens vesicle to the cor-
neal ectoderm hindered the migration of neural crest
cells across the stromal space between the surface ec-
toderm and endothelium as shown by X-gal staining of
Msx2/;R26R;Wnt1-Cre mouse embryonic sections(Figure 4, E and F). The development of both the corneal
stroma and endothelial cells were interrupted. By E14.5
days, the lens stalk was still present, adhering to cornea
and lens and further hindering the development of the
cornea. Lens vesicle was smaller than normal and lens
fiber cells distributed in disarray in the lens vesicle. In
addition, the typically single-layered anterior lens epi-
thelium frequently became multilayered in Msx2-defi-
cient mice and some lens fiber cells failed to be denu-
cleated. Abnormal mesenchyme filled in vitreous
cavity. The retina displayed abnormal proliferation and
folding that lead to shrinkage of the eye (Figure 3, M
versus O). The characteristic bowtie region formed by
the lens nuclei that was present in the WT lens (Figure
3P) was either less pronounced or completely absent
(Figure 3N).
Reduction of FoxE3 Expression in the Lens of
Msx2-Deficient Mice
In the lens vesicles of Msx2-deficient mice, the expres-
sion levels of both Ap2 and Pax6 were not altered (Fig-
ure 5, A–F). This finding suggests that Msx2 may function
in parallel to or downstream of the Ap2 and Pax6 genes.
Nonradioactive RNA in situ hybridization was then per-
formed to detect FoxE3 and major intrinsic protein (Mip)
transcripts. At E10.5 and E11.5, FoxE3 expression was
Figure 4. Smaller lens and persistent lens stalk
in eyes of the Msx2-deficient mice. Micrographs
of the whole mount (A and B) or cryosections
(C and D) of the eyes from embryos at E11.5.
GFP under the control of the Pax6 promoter
helps to illuminate the lens (white arrowhead).
In the LeCre;Msx2/ embryo, GFP illuminated
the lens (B) and the lens stalk (white arrow)
(D). WT mice are shown in A and C. A section
stained with X-gal (blue stained) demonstrates
contribution of neural crest to the stroma and
endothelium of the normal cornea in this eye
from a Msx2/;R26R;Wnt1-Cre embryo at
E15.5 (E). Corneal stroma is populated by cells
of neural crest origin as shown here by cells
stained blue. In the Msx2/;R26R;Wnt1-Cre
embryonic eye, persistent adhesion of the lens
(Le) to the overlying ectoderm hinders the mor-
phogenesis of the cornea (F). Neural crest–de-
rived corneal stroma is prevented by the lens
from migrating across the midsection of the cor-
nea (black arrowheads). A population of cells
originated from the neural crest found their des-
tination in the vitreous (black arrow) along
with some retinal neurons (F). Re, retina; Le,
lens.
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Msx2-deficient mice (Figure 6, A–D). At E12.5, FoxE3 was
only expressed in the anterior lens epithelial cells and not
in the differentiated lens fiber cells in WT mice (Figure
6E), whereas in the Msx2-deficient mice, FoxE3 tran-
Figure 5. Loss of Msx2 activity does not alter Pax6 and Ap2 expression.
Protein expression in WT and Msx2-deficient embryos, respectively, was
examined by immunofluorescence for Pax6 on E9.5 (A and B) and E11.5
(C and D), Ap2- (E –F), and crystallin on E11.5 (G and H) and E12.5 (I and
J). At the lens vesicle stage of eye development, the intensity and the spatial
domain of immune-reactivity are not altered significantly. Immunofluores-
cence of WT and Msx2-deficient embryonic eyes at E11.5 and E12.5 show
significant overexpression of - and -crystallin in the Msx2-deficient lens
vesicle (G–J). Scale bars: 50 m (A and B), 100 m (C–J). Re, retina; Le, lens;
OV, optic vesicle.scripts were completely absent in the lens vesicles (Fig-ure 6F). No change was seen in the expression of Mip in
lens fiber cells (Figure 6, I and J).
The expression of FoxE3 was studied in -TN4 and
C2C12 cell lines that were transfected with pEGFP-Msx2
as described.33 Primers used in quantitative real-time RT-
PCR are listed in Table 1. Expression of FoxE3 increased
28.53-fold in cell lines overexpressing Msx2, comparing
with the same cell lines transfected with pEGFP-C1 plasmid
(see Supplemental Figure S1 at http://ajp.amjpathol.org).
Figure 6. FoxE3 and Prox1 expression in the developing lens vesicle are
altered in Msx2-deficient mice. mRNA expression in WT and Msx2-deficient
embryos, respectively, was examined for FoxE3 at E10.5 (A and B), E11.5
(C and D), and E12.5 (E and F), Prox1 at E12.5 (G and H), and MiP at E12.5
(I and J). A: At E10.5, FoxE3 transcripts are present in the invaginated lens
vesicle but absent from the anterior region of the fusing vesicle in the WT
lens vesicle. B: Similar expression pattern is detected in the Msx2-deficient
mice, although the level of expression is reduced. At E11.5, FoxE3 is ex-
pressed throughout the lens in the WT embryo (C), whereas in the Msx2-
deficient mice, its expression is reduced in the posterior half and barely
detectable in the anterior half of the lens (D). At E12.5, FoxE3 expression is
restricted to the primary lens epithelium in the WT embryo (E) but
undetectable in the Msx2-deficient lens (arrows) (F). The expression of
Prox1 is elevated in the Msx2-deficient mouse lens vesicle at E12.5 (G)
compared with WT mice (H). The expression level of Mip, a lens differ-
entiation marker, does not differ between WT (I) and Msx2-deficient (J)
mouse lens vesicle at E12.5. Scale bars: 50 m (A and B), 75 m (C and D), 100
m (E–J). Re, retina.
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the Lens of the Msx2-Deficient Mice
At E12.5, when lens begin to differentiate, Prox1 expres-
sion in the lens vesicle was found to be augmented
significantly in theMsx2-deficient mice by nonradioactive
RNA in situ hybridization (Figure 6, G and H). Both the -
and -crystallin, the maker proteins for lens development,
were also significantly overexpressed in the lens vesicles
at E11.5 and E12.5 (Figure 5, G–J), whereas at E11.5,
only very weak - and -crystallin expression was seen in
the lens of the WT mice (Figure 5G), indicating that lens
differentiation started inappropriately early in the Msx2-
deficient mice.
Msx2 Regulates Cell Proliferation and Apoptosis
in the Lens Vesicle
To examine lens epithelial cell proliferation, in vivo BrdU
labeling was performed. The rate of BrdU incorporation at
E10.5 was indistinguishable between control and the
Msx2-deficient mice in the lens vesicles (Figure 7, A and
B). At E11.5, the lens vesicles in the Msx2-deficient
mice appeared conspicuously smaller in size and la-
beled cells disarrayed within the lens vesicle, whereas
most of labeled cells were localized at the anterior
portion of the lens vesicle in WT lens (Figure 7, C and
D). The absolute number of lens cells that incorporated
BrdU was significantly reduced in the Msx2-deficient mice
compared with that of the WT (data not shown), but the
ratio of BrdU-labeled cells to unlabeled cells was virtually
identical between the Msx2-deficient and the WT mice
(n  4, P  0.05).
We also evaluated the proliferation rate at E14.5 and
E15.5, a relatively late stage of lens development. Cell
counting was conducted according to a protocol modi-
fied from previous studies.47 We found that the BrdU
labeling rate in lens epithelial cells was the lowest in the
0° to 15° sector in both the Msx2-deficient and the WT
mice, and there is no significant difference between the
two groups at E14.5 and E15.5 (Figure 7, E–H). In this
sector, cells begin to withdraw from the cell cycle in
preparation for fiber cell terminal differentiation. The BrdU
labeling rate was found to be significantly increased in
central lens epithelial cells (60° to 90° sectors) at E14.5
and E15.5 in the Msx2-deficient mice compared with the
WT mice (P  0.01). However, in the 15° to 45° sectors
BrdU-labeling rates were significantly lower in the Msx2-
deficient mice at E15.5 (P 0.01), whereas no difference
was found at E14.5 in this sector compared with the WT
Table 1. Primers Used in Quantitative Real-Time RT-PCR
Primer Sequence
FoxE3 5=-TCTAACGCTGGCAGCCATCTAC
ACGAAACAGTCGTTGAGGGTGAG-3=
-Actin 5=-CATCCGTAAAGACCTCTATGCCAAC
ATGGAGCCACCGATCCACA-3=mice (Figure 7, I and J).We further examined programmed cell death by per-
forming in situ TUNEL assay and detected significantly
higher level of apoptotic events in lenses of the Msx2
deficient mice at E11.5 (Figure 8, A–C, P  0.01).
Discussion
In this study, using conventionalMsx2 KO mice, we dem-
onstrated that Msx2 is a significant contributor to eye
development. Without the Msx2 gene, mice are born with
Figure 7. Proliferation rate changes in the lens after loss of Msx2 expression,
as assessed by BrdU incorporation in the lens vesicles. Comparable numbers
of lens cells are undergoing cell division in WT and Msx2-deficient embryos,
respectively, at E10.5 (A and B), E11.5 (C and D), E14.5 (E and F), and E15.5
(G and H). The percentage of BrdU-labeled lens cells is not statistically
significant betweenMsx2-deficient mice and WT mice at E10.5 and E11.5, but
BrdU-labeled lens cells are less at E11.5 in Msx2-deficient mice compared
with WT. I and J: Histogram showing the mean ratio of BrdU-labeled lens
cells at E14.5 (I) and E15.5 (J). BrdU-labeling rate significantly increased in
central lens epithelial cells in the Msx2-deficient mice at E14.5 and E15.5, and
the proliferation of lens epithelial cells around the equator is disturbed in the
Msx2-deficient mice at E15.5 (equators marked by black lines). *P  0.01.
Scale bars: 50 m (A–D), 75 m (C andD), 100 m (E and G), 150 m (F and
H). Re, retina; Le, lens.
rial sect
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developmental disease in human. Both the Le-Cre and
Wntl-Cre transgenic mouse lines were used in this study
to better reveal the persistent lens stalk and address the
relationship between the lens and cornea in early stages
of eye development. The use of Le-Cre mice helped us to
demonstrate persistent lens stalk through GFP expres-
sion, which is under the control of the lens ectoderm
promoter of Pax6 in such mice.44 UsingWnt1-Cremice, in
which -galactosidase reporter gene expression in the
Rosa26 knock-in allele is mediated by the Wnt-1 pro-
moter controlled Cre recombinase, we demonstrated that
cornea development was hindered by persistent lens
stalk. Our findings suggest that Msx2 is embedded in the
transcriptional network, which governs the morphoge-
netic processes of early eye development in vertebrates.
Proper development of the eye relies on coordinated
interactions among the surface ectoderm, lens, optic
cup, and periocular neural crest mesenchyme. Signals
from the lens have been shown to be critical for early eye
development.48 In addition, the lens itself plays amajor role
during innervation of the cornea.48 It is known that Msx2
controls target gene transcription by forming activating or
suppressing protein-protein complexes.8,25,35,36,41 These
Msx2-interacting partners are the likely contributors to phe-
notypic variability in the Msx2-deficient animals. Loss of
function of Msx2 led to a range of eye defects, with a
minuscule lens vesicle and persistent lens stalk the most
severe phenotypes, as observed in our study. In the most
severe cases, retina exhibited folding due to reduced
ocular volume, and laminar structure of the retina was
compromised.
Previous studies have established a provisional ge-
netic pathway that controls this morphologic process,
leading to apoptosis and elimination of the lens stalk after
lens vesicle closure.49,50 Central to this genetic regula-
tory pathway is the FoxE3 gene.51 FoxE3mutation causes
ASD, with ocular phenotypes ranging from microcornea
to Peters anomaly in human.52 Mutant mice with consid-
erable reduction in FoxE3 expression showed severely
malformed lens with persisting lens stalk during early eye
development, and the lens epithelium remained in con-
tact with the corneal epithelium.48 Several transcriptional
factors have been shown to regulate FoxE3 expression,
and among these are Pax6, Mab21L1, Zeb2 (former
Figure 8. Loss of Msx2 expression influences the apoptotic response in the
observed in the lens vesicle and some apoptotic cells are found in the retin
vesicle. C: Histogram showing the mean number of apoptotic lens cells of se
significant at E11.5. Scale bars  50 m. Re, retina; Le, lens.name Sip-1), AP-2, Six3, Pitx3, Otx2, and KLF4.50,53–59To gain understanding at the molecular level of the per-
sistent corneal-lentoid adhesion phenotype in the Msx2-
deficient animals, we investigated the expression of
Pax6, Ap2, and FoxE3. We found FoxE3 expression was
significantly reduced in the lens vesicles in the Msx2-
deficient mice. Because elevated expression of FoxE3
was seen in the cell lines overexpressing Msx2, we con-
clude that Msx2 can up-regulate the expression of FoxE3
in the early stage of lens development. One explanation
could be that such adhesion is caused by a dysregula-
tion of genes responsible for apoptosis within the corneal
stalk, which is thought to degrade during lens morpho-
genesis as a result of apoptosis. An alternative explana-
tion could be that down-regulation of FoxE3 may cause a
dysregulation of cadherin proteins, such as E-cadherin,
which is present in the corneal stalk.49
To learn more about the signaling pathways in which
Msx2 influences ocular development, we investigated the
expression of Prox1, which was found to affect the termi-
nal differentiation and elongation of lens fiber cell through
regulating the Cdkn1c which controlled the cell cycle.60
Given that Prox1 was shown to function downstream of
FoxE3 and its expression was suppressed by FoxE3,51 it
was not surprising to see that Prox1 expression was
up-regulated in the lens vesicles of the Msx2-deficient
mice due to reduced FoxE3 expression. Nevertheless,
the possibility that Msx2 may directly suppress Prox1
transcription cannot be ruled out. The mechanism as to
how Msx2 achieves its regulatory activity on FoxE3
and/or Prox1 awaits further investigation. Ectopic expres-
sion of Prox1 in the mouse retina was found to force
retinal progenitor cells to exit the cell cycle.61 Further-
more, results from several other studies supported the
role of Prox1 in promoting neuronal differentiation and
cell cycle withdraw. This prodifferentiation function of
Prox1 appears to be evolutionarily conserved among fish,
chicks, and mice.62,63 Thus, it is reasonable to hypothe-
size that the high level of Prox1 expression found in the
lens of the Msx2-deficient mice may lead to premature
cell cycle withdrawal and thus promote cell differentia-
tion. Because of FoxE3 and Prox1 malfunction in the
Msx2-deficient mice, precocious crystallin expression
occurred. Disturbed lens cell cycle in the lens vesicles
might explain themicrophthalmia seen in theMsx2-deficient
sicle at an early stage (E11.5). A: In the WT embryo, few apoptotic cells are
the Msx2-deficient embryos, more apoptotic cells are observed in the lens
ions. The difference between Msx2-deficient and WT embryos is statisticallylens ve
a. B: Inmice. Furthermore, the failure of the lens in detaching from
2238 Zhao et al
AJP June 2012, Vol. 180, No. 6the surface ectoderm in these mice may have also contrib-
uted to the disruption to further growth of the lens.
Because 100% of the Msx2-deficient mice showed
persistence of the lens vesicles, we looked at cell prolif-
eration and apoptosis in the early stage of lens develop-
ment. We did not observe changes in the proliferation
rate, and there was a high level of cell death in the central
lens epithelium and in theMsx2-deficient mice at an early
stage. Our previous studies found that overexpressed
Msx2 could result in microphthalmia due to inhibited pro-
liferation in lens vesicles.41 It was suggested that the
overlapping of Msx2 malfunction and FoxE3 reduction
resulted in the normal proliferation rate in the Msx2/
mice at an early stage. Thus, the smaller lens vesicle
seen can be attributed to apoptosis in the lens vesicles
and inappropriate early differentiation in the lens of the
Msx2-deficient mice. One previous study showed that
there were severe defects in proliferation and differenti-
ation of lens cells in FoxE3 null mice especially after
E14.5.48 Therefore, we investigated lens epithelium cell
proliferation change at E14.5 and E15.5. We found that
the BrdU-labeling rate significantly increased in central
lens epithelial cells in the Msx2-deficient mice. However,
the proliferation of lens epithelial cells around the equator
was disturbed, which affected the differentiation process
in the Msx2-deficient mice. We hypothesized that the
increase of lens epithelial cell proliferation in the central
region probably was due to lack of suppression for such
proliferation from the Msx2-deficient mice and the result-
ing persistent lens stalk beginning at a relatively later
stage. The proliferation changes around the equator at
E15.5 in the Msx2-deficient mice were consistent in part
with a previous report that FoxE3 expression affects the
lens epithelial cell proliferation at a later stage during lens
development.
In summary, our morphologic study provided the first
direct genetic evidence of the role of MSX2 in Peters
anomaly and the distinct function of MSX2 in regulating
the growth and development of lens vesicle. The ob-
served changes in the expression of FoxE3 and Prox1
further support the importance of MSX2 in controlling
transcription of target genes critical for early eye devel-
opment. Further investigation into these complex interac-
tions among MSX2 and various transcriptional regulators
and signaling molecules in directing growth and morpho-
genetic events in the developing eye should help clarify
the pathogenesis of ASD and other congenital eye dis-
eases. Thus far, mutations in genes such as PAX6, PITX3,
and SOX1 have been identified in cases of Peters anom-
aly in humans.5,64,65 We suggest genetic testing ofMSX2
mutations be included in patients with a clinical diagnosis
of Peters anomaly in the future to corroborate our findings
in this animal study.
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